New weight loss drug to be sold on Trump's pharmaceutical cost comparison platform - CBS News

New weight loss drug to be sold on Trump's pharmaceutical cost comparison platform  CBS NewsThe FDA approves a new obesity pill, giving patients another option  NPRA new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.  Business InsiderFDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions  Eli LillyF.D.A. Approves New Weight-Loss Pill  The New York Times